Ultraviolet recall dermatitis reaction with sorafenib.
Fiche publication
Date publication
octobre 2011
Journal
Investigational new drugs
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MERROUCHE Yacine
Tous les auteurs :
Magné N, Chargari C, Auberdiac P, Moncharmont C, Merrouche Y, Spano JP
Lien Pubmed
Résumé
Recall dermatitis is a rare and poorly understood drug-related event. Activated by exposure to sunlight or Ultraviolet (UV), drug-related phototoxic reactions have been reported with conventional chemotherapy agents or antibiotics.
Mots clés
Benzenesulfonates, adverse effects, Fatal Outcome, Humans, Male, Middle Aged, Niacinamide, analogs & derivatives, Phenylurea Compounds, Protein Kinase Inhibitors, adverse effects, Pyridines, adverse effects, Radiodermatitis, chemically induced, Ultraviolet Rays, adverse effects
Référence
Invest New Drugs. 2011 Oct;29(5):1111-3